title: Opportunities and perspectives for developing orexin receptor antagonists.
authors: Actelion Pharmaceuticals Ltd., Department of Central Nervous System (CNS) Pharmacology Allschwil, Switzerland.
authors: Michel A
authors: MA
authors: Steiner
authors: Merck Research Laboratories, Department of Neuroscience West Point, PA, USA.
authors: Christopher J
authors: CJ
authors: Winrow
keywords: addiction; anxiety; hypocretin; insomnia; neuropeptide; neuroscience; orexin; orexin receptor antagonist